$ELRE
Yinfu Gold Corp.

2023 Q2 Form 10-K Financial Statement

#000164033423001168 Filed on June 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 2022
Revenue $0.00 $58.40K $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $58.40K $0.00
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $11.34K $430.4K $472.8K
YoY Change -90.58% -8.97% 65.04%
% of Gross Profit 736.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $74.90K
YoY Change 2.55%
% of Gross Profit
Operating Expenses $11.34K $430.4K $472.8K
YoY Change -90.58% -8.97% 65.04%
Operating Profit -$11.34K -$372.0K -$472.8K
YoY Change -90.58% -21.32% 65.04%
Interest Expense $0.00 $0.00 $1.00
YoY Change -100.0% 0.0%
% of Operating Profit
Other Income/Expense, Net $658.00 $900.00 -$417.00
YoY Change -21.01% -315.83% -349.7%
Pretax Income -$10.68K -$371.1K -$473.2K
YoY Change -91.07% -21.58% 65.28%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.68K -$371.1K -$473.2K
YoY Change -91.07% -21.58% 65.28%
Net Earnings / Revenue -635.41%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.19 -$238.6K
COMMON SHARES
Basic Shares Outstanding 1.984M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $730.00 $900.00 $530.00
YoY Change -52.6% 69.81% 76.67%
Cash & Equivalents $726.00 $900.00 $530.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.991K $10.32K $6.840K
YoY Change 14.38% 50.88% 242.0%
LONG-TERM ASSETS
Property, Plant & Equipment $4.130K $2.600K $6.480K
YoY Change -89.63% -59.88% -91.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.133K $2.600K $6.480K
YoY Change -89.62% -59.88% -91.86%
TOTAL ASSETS
Total Short-Term Assets $9.991K $10.32K $6.840K
Total Long-Term Assets $4.133K $2.600K $6.480K
Total Assets $14.12K $12.92K $13.32K
YoY Change -70.91% -3.0% -83.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $242.4K $231.7K $177.4K
YoY Change 23.21% 30.63% 77.95%
Accrued Expenses $440.00 $6.460K $26.48K
YoY Change -98.91% -75.6% -73.12%
Deferred Revenue
YoY Change
Short-Term Debt $23.44K $286.7K $228.7K
YoY Change -90.07% 25.36% 33.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.588M $2.621M $2.458M
YoY Change 1.25% 6.63% 21.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.280K $0.00
YoY Change
Total Long-Term Liabilities $4.280K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.588M $2.621M $2.458M
Total Long-Term Liabilities $4.280K $0.00 $0.00
Total Liabilities $2.592M $2.621M $2.458M
YoY Change 1.42% 6.63% 21.37%
SHAREHOLDERS EQUITY
Retained Earnings -$2.783M
YoY Change 10.4%
Common Stock $122.0K
YoY Change 6048.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.578M -$2.608M -$2.444M
YoY Change
Total Liabilities & Shareholders Equity $14.12K $12.92K $13.32K
YoY Change -70.91% -3.0% -83.68%

Cashflow Statement

Concept 2023 Q2 2023 2022
OPERATING ACTIVITIES
Net Income -$10.68K -$371.1K -$473.2K
YoY Change -91.07% -21.58% 65.28%
Depreciation, Depletion And Amortization $74.90K
YoY Change 2.55%
Cash From Operating Activities $4.356K -$71.38K -$172.8K
YoY Change -109.03% -58.69% -50.38%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.656K 71.78K $173.0K
YoY Change -94.61% -58.5% -50.25%
NET CHANGE
Cash From Operating Activities $4.356K -71.38K -$172.8K
Cash From Investing Activities $0.00 $0.00 $0.00
Cash From Financing Activities $2.656K 71.78K $173.0K
Net Change In Cash -$170.00 400.0 $225.00
YoY Change -116.68% 77.78% -147.37%
FREE CASH FLOW
Cash From Operating Activities $4.356K -$71.38K -$172.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-371084 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001438461
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 dei Entity Public Float
EntityPublicFloat
0 usd
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1983993 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1983993 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1983993 shares
CY2023 us-gaap Interest Paid
InterestPaid
0 usd
CY2022 us-gaap Interest Paid
InterestPaid
0 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-152242
CY2023 dei Entity Registrant Name
EntityRegistrantName
YINFU GOLD CORPORATION
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8531222
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 2313
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Dongfang Science and Technology Mansion
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
Nanshan District
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Shenzhen
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
518000
CY2023 dei City Area Code
CityAreaCode
755
CY2023 dei Local Phone Number
LocalPhoneNumber
8316-0998
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Security12b Title
Security12bTitle
Common stock
CY2023 dei Trading Symbol
TradingSymbol
ELRE
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1983993 shares
CY2023 dei Auditor Firm
AuditorFirmId
6255
CY2023 dei Auditor Name
AuditorName
Pan-China Singapore
CY2023 dei Auditor Location
AuditorLocation
Singapore
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
896 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
525 usd
CY2023Q1 us-gaap Other Receivables
OtherReceivables
9426 usd
CY2022Q1 us-gaap Other Receivables
OtherReceivables
6315 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
10322 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
6840 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2602 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6481 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
2602 usd
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
6481 usd
CY2023Q1 us-gaap Assets
Assets
12924 usd
CY2022Q1 us-gaap Assets
Assets
13321 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
231738 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
177395 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
24749 usd
CY2022Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
0 usd
CY2023Q1 elre Short Term Loan Related Party
ShortTermLoanRelatedParty
261932 usd
CY2022Q1 elre Short Term Loan Related Party
ShortTermLoanRelatedParty
228675 usd
CY2023Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
453 usd
CY2022Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
480 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6007 usd
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
26003 usd
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2095837 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2025195 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2620716 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2457748 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2620716 usd
CY2022Q1 us-gaap Liabilities
Liabilities
2457748 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1983993 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1984 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1984 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7934 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7934 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2772553 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2401469 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
154843 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52876 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2607792 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2444427 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12924 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13321 usd
CY2023 elre Revenuenet
Revenuenet
58395 usd
CY2022 elre Revenuenet
Revenuenet
0 usd
CY2023 us-gaap Revenues
Revenues
58395 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023 us-gaap Gross Profit
GrossProfit
58395 usd
CY2022 us-gaap Gross Profit
GrossProfit
0 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
369667 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
416283 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
60715 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
56520 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
430382 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
472803 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-371987 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-472803 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-900 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
418 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
903 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-417 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-371084 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-473220 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-371084 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-473220 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
207719 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-27901 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-163365 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-501121 usd
CY2023 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.19
CY2022 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.24
CY2023 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2022 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1943306 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-473220 usd
CY2022 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-27901 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2444427 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-371084 usd
CY2023 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
207719 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-2607792 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-473220 usd
CY2023 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
31310 usd
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
74895 usd
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-114823 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
4508 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
317966 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
304957 usd
CY2023 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-45967 usd
CY2022 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-74895 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47048 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-172771 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 elre Borrowing From Third Party Loan
BorrowingFromThirdPartyLoan
24818 usd
CY2022 elre Borrowing From Third Party Loan
BorrowingFromThirdPartyLoan
0 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables that it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p>
CY2023 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
47680 usd
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
52440 usd
CY2023 elre Proceeds From Related Party Debts
ProceedsFromRelatedPartyDebts
-120714 usd
CY2022 elre Proceeds From Related Party Debts
ProceedsFromRelatedPartyDebts
120541 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-48216 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
172981 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1539 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
371 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
225 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
525 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
300 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
896 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
525 usd
CY2007Q1 elre Common Stock Increase Authorized Capital Shares
CommonStockIncreaseAuthorizedCapitalShares
1000000000 shares
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments. </p>
CY2023 us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations or balance sheets. An reclassification has been made to the Consolidated Statement of Cash Flows as of March 31, 2022 to reclassify wage payable to related party of $251,778 to accounts payable and accrued liabilities.</p>
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
251778 usd
CY2023 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
207719 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
-27901 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-371084 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-473220 usd
CY2023 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2022 elre Weighted Average Number Of Share Outstanding Basic And Diluted Share
WeightedAverageNumberOfShareOutstandingBasicAndDilutedShare
1983993 shares
CY2023 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.19
CY2022 elre Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.24
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2095837 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2025195 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-371084 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1983993 shares
CY2023Q1 elre Accrued Interest Related Parties
AccruedInterestRelatedParties
453 usd
CY2022Q1 elre Accrued Interest Related Parties
AccruedInterestRelatedParties
480 usd
CY2023Q1 us-gaap Due From Related Parties
DueFromRelatedParties
261932 usd
CY2022Q1 us-gaap Due From Related Parties
DueFromRelatedParties
228675 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
6007 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
0 usd
CY2023Q1 elre Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal Remainder Thereafter
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderThereafter
0 usd
CY2023Q1 elre Lease Payment At Present Value
LeasePaymentAtPresentValue
6007 usd
CY2020Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
143508 usd
CY2017Q4 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Tax Reform Act permanently reduces the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. As a result of the reduction in the U.S. corporate income tax rate from 34% to 21% under the Tax Reform Act, the Company revalued its ending net deferred tax assets

Files In Submission

Name View Source Status
0001640334-23-001168-index-headers.html Edgar Link pending
0001640334-23-001168-index.html Edgar Link pending
0001640334-23-001168.txt Edgar Link pending
0001640334-23-001168-xbrl.zip Edgar Link pending
elre-20230331.xsd Edgar Link pending
elre_10k.htm Edgar Link pending
elre_ex311.htm Edgar Link pending
elre_ex312.htm Edgar Link pending
elre_ex321.htm Edgar Link pending
elre_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
elre-20230331_cal.xml Edgar Link unprocessable
elre-20230331_def.xml Edgar Link unprocessable
elre-20230331_lab.xml Edgar Link unprocessable
elre-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elre_10k_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending